| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate |
2000-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7017ee46a4986c5c9e5de6696748161a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d0598c2fe11492babd0adea30de49de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ec3d635667b24a1a6cad2974f86ffdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72a24e00d8eb2c1b0227a22c50387113 |
| publicationDate |
2002-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2369362-A |
| titleOfInvention |
Modulators of inwardly rectifying potassium channels |
| abstract |
The present invention provides the use of a substance which modulates inwardly rectifying potassium channel (Kir) activity of a polypeptide, which polypeptide comprises: <SL> <LI>(a) the amino acid sequence of SEQ ID NO: 2; or <LI>(b) a variant thereof which is a potassium channel activated by hyperpolarisation of cell membrane potential below the reversal potential for potassium; or <LI>(c) a fragment of (a) or (b) which is a potassium channel activated by hyperpolarisation of cell membrane potential below the reversal potential for potassium; </SL> in the manufacture of a medicament for the treatment or prophylaxis of a cerebellar or spinocerebellar disorder, a thyroid disorder or a kidney disorder. |
| priorityDate |
2000-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |